KHKoichi Hayashi

Koichi Hayashi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Koichi Hayashi has a total of 103 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • PS 08-11 THE EFFECT OF MINERALOCORTICOID ANTAGONIST ON RENAL INSULIN RESISTANCE AND THE PROGRESSION OF RENAL FAILURE IN NON-DIABETIC CKD PATIENTS

    by Hitoshi Minakuchi, Shu Wakino, Kazuhiro Hasegawa, Takeshi Kanda, Hirobumi Tokuyama, Koichi Hayashi, Hiroshi Itoh

    Insulin resistance (IR) is evident in Chronic Kidney Disease (CKD ) even in non-diabetic patient, although the clinical relevances remain to be determined. We reported that aldosterone increase in CKD is contributed to IR in CKD and MR antagonist, spironolactone ameliorated IR in CKD in three months treatment. We follow our CKD cohort for five years and explored the relevance of IR in the progression of CKD. We also performed procebo-controlled clinical trial using mineralocorticoid receptor antagonist eplerenone and examined its effects on the progression of CKD. Between 2007 and 2008, consecutive 197 patients with CKD were enrolled and followed these patients for five years. Risk factors for the progression of CKD evaluated by the rate of eGFR decline was determined by multiple regression analysis. We recruited the patients with hyperaldosterone and IR patients (N = 48) and treated them with eprelenone (N = 22) and placebo (N = 26) for three years and evaluated its effect on eGFR decline. In CKD patients, HOMA-IR levels were negatively associated with eGFR levels. Plasma aldosterone concentration was determined as an independent risk factor for HOMA-IR levels. After three years follow-up, baseline HOMA-IR levels was significantly associated with eGFR decline and selected as a independent risk factor. We classified quartile groups depending on the baseline HOMA-IR levels and found out the 3rd and 4th quartile groups were significantly higher decline in eGFR. Finally, eplereneone ameliorated eGFR decline of non-diabetic CKD patients with high HOMA-IR and high plasm aldosterone levels(eplerenone; eGFR 51.0 ± 3.7→50.4 ± 3.4 ml/min, placebo; eGFR 55.6 ± 5.1→53.1 ± 4.7 ml/min). IR is a risk factor of the progression of CKD and mineralocorticoid receptor antagonist will provide a novel strategy against the progression of CKD through the amelioration of IR.

    • 1 January 2016
      • Vol. 58  (1) , 45-54

    [Renal thrombotic microangiopathy and antiphospholipid syndrome nephropathy in a patient with lupus nephritis].

    by Yusuke Sakamaki, Konosuke Konishi, Akinori Hashiguchi, Shigeki Tomita, Eiji Kubota, Hiroshi Itoh, Koichi Hayashi

    The patient was a 48-year-old Japanese woman diagnosed as having systemic lupus erythematosus at the age of 21 years when she presented with fever and an erythematous skin rash on her face and extremities. Prednisolone was initiated at that time. Thirteen days before admission to our hospital, she was referred to us by her family physician. Upon admission, blood tests showed pancytopenia, hypocomplementemia, and renal dysfunction, as well as the presence of lupus anticoagulant. Urinalysis showed abundant proteinuria and heavy microscopic hematuria. After performing a renal biopsy, we initiated immunosuppressive therapy and an anticoagulant. On the 22nd hospital day, microangiopathic hemolytic anemia appeared with the progression of thrombocytopenia and renal failure, and the patient subsequently underwent ten sessions of plasma exchange. After the commencement of the plasma exchange, her general condition improved. Her renal dysfunction, however, continued to progress, and hemodialysis was started on the 36th hospital day. The light microscopy showed severe endo- and extra-capillary proliferative glomerulonephritis with abundant crescents, and massive thrombi in the capillary lumen of the glomeruli. The arterioles contained occlusive hyaline materials. An immunofluorescence study showed granular staining of immunoglobulins and complements along the glomerular capillary wall. An electron microscopy examination revealed the presence of electron-dense deposits in the subepithelial and intramembranous areas of the glomeruli, but subendothelial deposits were absent. For cases with lupus nephritis (LN), immunosuppressive therapy based on corticosteroid remains the mainstay of treatment. However, immunosuppression alone may be insufficient when antiphospholipid antibody syndrome and thrombotic microangiopathy (TMA) are also present, and other treatment modalities including antiplatelet therapy, anticoagulation, and plasma exchange are likely to be necessary, as illustrated by the present case. Although the mechanism responsible for LN remains uncertain, we report a case of LN suggesting that TMA is associated with renal dysfunction.

  • Comparison of the effects of low-dose rosuvastatin on plasma levels of cholesterol and oxidized low-density lipoprotein in 3 ultracentrifugally separated low-density lipoprotein subfractions

    by Koichiro Homma, Yasuhiko Homma, Hideki Ozawa, Yutaka Shiina, Takeo Shibata, Tadashi Yoshida, Kazuhiro Hasegawa, Takeshi Kanda, Hirobumi Tokuyama, Shu Wakino, et al.


    • 1 January 2015
      • Vol. 31, 59-68

    Impact of Peritoneal Dialysis Catheter Insertion by a Nephrologist: Results of a Questionnaire Survey of Patients and Nurses.

    by Naoki Washida, Kayoko Aikawa, Shuji Inoue, Takahiro Kasai, Keisuke Shinozuka, Kohkichi Morimoto, Kozi Hosoya, Koichi Hayashi, Hiroshi Itoh

    Peritoneal dialysis (PD) is an excellent dialysis mo- dality, but it is underutilized in the United States and Japan. In the present study, we evaluated the impact of interventional nephrology in PD on the impres- sions held by patients and nurses about selection of a renal replacement therapy and the complications associated with PD therapy. Over aperiod of 7 years, PD catheter insertion in 120 patients with end-stage renal disease (age: 63.0 ± 13.3 years) was performed by nephrologists at Keio University Hospital or Saitama Medical Center. A questionnaire survey evaluating the advantages and disadvantages of this interventional nephrology approach in PD was distributed to 72 PD patients and to 53 nurses in charge of those patients. After interventional nephrology in PD was adopted, the number of patients selecting PD therapy increased. The incidence of peritonitis was relatively low (1 episode in 101.1 patient-months). Responses to the questionnaire survey showed that neither patients nor nurses were concerned about catheter insertion by physicians, and no communication problems between the patients, nurses, and physicians were reported. Approximately 60% of the nurses specializing in PD therapy showed higher motivation with interventional nephrology, which might have a favorable effect on the selection of PD therapy, on the incidence of peritonitis, and on the tripartite communication between patients, nurses, and physicians.

  • 5/6 Nephrectomy reduces muscle mitochondria in mice as to decrease exercise endurance associated with further exacerbation by dietary protein

    by Masanori Tamaki, Kazutoshi Miyashita, Shu Wakino, Masanori Mitsuishi, Koichi Hayashi, Hiroshi Itoh

    Introduction: Chronic kidney disease impairs physical performance from an early stage of disease, and the impairment is a critical medical problem because lowered physical activity correlates with renal prognosis and mortality, and constitutes an independent cardiovascular risk for chronic kidney disease patients, with as high an impact as hypertension and diabetes. In this study, the time course and mechanism of muscle insufficiency in renal failure were investigated using 5/6 nephrectomized (5/6Nx) mice, a model of mild chronic kidney disease. Furthermore, the effect of high-protein diet on chronic kidney disease was examined. Methods: C57bl/6 mice which had undergone 5/6 nephrectomy at 6–7 weeks were examined for physical performance in young (16–20 weeks old) and aged (48–52 weeks old) groups. Protein adjusted diets were fed from 8 weeks old. Results: A decrease in muscle mitochondria and running distance was identified in young 5/6Nx mice, despite the preservation of muscle volume and power. Thereafter, a decrease in muscle volume associated with a reduction in muscle power became apparent in aged 5/6Nx mice. A high-protein diet feeding from 8 weeks old increased muscle volume and power in the mice; however, it further decreased running distance, associated with a decrease in the activity of pyruvate dehydrogenase which promotes aerobic glycolysis. Activation of pyruvate dehydrogenase by dichroloacetate effectively recovered running distance which was decreased by dietary protein. Conclusion: A decrease in muscle mitochondria was identified as a new mechanism for the reduction in exercise endurance of 5/6 nephrectomy mice. Decreased pyruvate dehydrogenase activity accounted for the further reduction in exercise endurance by dietary protein. These findings clarify the mechanism of muscle insufficiency in renal failure and suggest activation of muscle mitochondria as a potential strategy for the improvement of physical performance of patients with chronic kidney disease.

  • Open Access

    MPO-ANCA associated crescentic glomerulonephritis with numerous immune complexes: case report

    by Ryuji Morizane, Konosuke Konishi, Akinori Hashiguchi, Hirobumi Tokuyama, Shu Wakino, Hiroshi Kawabe, Matsuhiko Hayashi, Koichi Hayashi, Hiroshi Itoh

    Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis (CGN) is a major cause of rapidly progressive glomerulonephritis (RPGN). ANCA-associated CGN is generally classified into pauci-immune RPGN, in which there are few or no immune complexes.


  • Open Access

    Nephritis Associated with Ulcerative Colitis

    by Hirobumi Tokuyama, Shu Wakino, Koichi Hayashi, Hiroshi Itoh

    Nephritis Associated with Ulcerative Colitis | InTechOpen, Published on: 2011-12-14. Authors: Hirobumi Tokuyama, Shu Wakino, Koichi Hayashi, et

  • Impact of renal function on cardiovascular events in elderly hypertensive patients treated with efonidipine

    by on behalf of the JATOS Study Group, Koichi Hayashi, Takao Saruta, Yoshio Goto, Masao Ishii

    This study evaluated the impact of renal function on cardiovascular outcomes in elderly hypertensive patients enrolled in the Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive patients. The patients were randomly assigned to either a strict-treatment group (target systolic blood pressure (BP) <140 mm Hg, n=2212) or a mild-treatment group (target systolic BP, 140 to <160 mm Hg, n=2206), each with efonidipine (a T/L-type Ca channel blocker)-based regimens. Cardiovascular events (stroke, cardiovascular disease and renal disease) were evaluated during the 2-year follow-up period following the prospective randomized open-blinded end-point method. Estimated glomerular filtration rate (eGFR) was elevated throughout the trial period in both the strict-treatment (59.4-62 ml min⁻¹ per 1.73 m²) and the mild-treatment group (58.8-61.4 ml min⁻¹ per 1.73 m²). This tendency was also observed in diabetic patients and patients aged ≥75 years, with baseline eGFR<60 ml min⁻¹ per 1.73 m². Baseline eGFR (<60 vs. ≥60 ml min⁻¹ per 1.73 m²) had no definite relationship with the incidence of cardiovascular events, nor did the level of BP control. Proteinuria at the time of entry into the study, however, was significantly correlated with cardiovascular event rates (7.1%), an association that was more apparent in patients with eGFR<60 ml min⁻¹ per 1.73 m² (8.2%). Furthermore, the event rate was more elevated in patients with greater declines in eGFR and was amplified when the baseline eGFR was <60 ml min⁻¹ per 1.73 m². In conclusion, the rates of decline of renal function and proteinuria constitute critical risk factors for cardiovascular events in elderly hypertensive patients, trends that are enhanced when baseline eGFR is diminished. Furthermore, the fact that efonidipine-based regimens ameliorate renal function in elderly hypertensive patients with chronic kidney disease may offer novel information on the mechanisms of cardiovascular protection.